Project Ronin

Project Ronin

Oncology care platform with data-guided insights

Overview

Project Ronin delivers a Cancer Intelligence Platform as a service to oncology providers (hospitals, cancer centers, and clinics). The platform combines a patient-facing app for symptom tracking and communication with a clinician-facing dashboard that aggregates health data, including treatment history, lab results, and genomic information. It uses data analytics to generate personalized insights and treatment recommendations to help oncologists make better-informed decisions and to improve the patient care experience. The subscription-based model targets the oncology market from small community practices to large academic centers. Unlike generic health IT tools, the platform is purpose-built for cancer care, integrating patient engagement with clinical decision support in a single system. The goal is to improve cancer outcomes and patient experience by enabling data-driven, timely clinical interventions and better coordination between patients and their care teams.

About Project Ronin

Simplify's Rating
Why Project Ronin is rated
F
Rated D- on Competitive Edge
Rated F on Growth Potential
Rated D- on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Seed

Total Funding

$35M

Headquarters

San Mateo, California

Founded

2018

Get referred to Project Ronin

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Oracle infrastructure and AI integration showed a technically credible enterprise healthcare stack.
  • Ronin built oncology data models trained on real clinical workflow and patient engagement.
  • Providence adoption demonstrated hospital willingness to trial the platform before shutdown.

What critics are saying

  • Bloomberg reported Ronin shut down on March 1, 2024 with permanent layoffs.
  • Ronin struggled to attract paying customers and ran out of cash by 2024.
  • Closure makes Ronin an existential dead-end unless a buyer acquires the intellectual property.

What makes Project Ronin unique

  • Oracle-backed oncology platform unified EMR, analytics, and patient symptom reporting.
  • Providence Saint John's selected Ronin in October 2022 for cancer workflow integration.
  • Ronin claimed Oracle AI cut oncologist data access from 20 minutes to under five.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$35M

Above

Industry Average

Funded Over

0 Rounds

Benefits

Remote-first company

Competitive salary & equity, based on experience

401k through Guideline

Medical, dental, & vision

100% covered life insurance

Parental Leave

Flexible vacation

11 paid company holidays + week off during the winter holidays

All the stipends!

Team lunches

Company News

Arrow Heart Publishing
Jul 11th, 2023
Ronin CSO Christine swisher, ph.d. joins CHAI to help advance Trustworthy AI in Healthcare

SAN FRANCISCO, July 11, 2023 /PRNewswire/ — Ronin, an innovator of evidence-based clinical decision support, today announced that its Chief Scientific Officer (CSO), Christine Swisher, Ph.D., has joined the Coalition for Health AI (CHAI) as an advisor.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Project Ronin right now.

Find jobs on Simplify and start your career today

We update Project Ronin's jobs every few hours, so check again soon! Browse all jobs →